MedPath

Comparative study of high flow nasal cannula and non invasive ventilation in patients with pneumonia.

Phase 2
Conditions
Health Condition 1: J960- Acute respiratory failureHealth Condition 2: J189- Pneumonia, unspecified organism
Registration Number
CTRI/2024/08/071774
Lead Sponsor
KP Salve Institure of Medical Sciences and Research Centre and Lata Mangeshkar Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with moderate to severe pneumonia (CURB65 more than 2) requiring oxygenation (PaO2/FiO2 less than 300) (PaO2 less than 60).

Patints more than 18 years of age.

Exclusion Criteria

Patients having contraindications of HFNC and NIV.

Patients requiring mechanical ventilation.

Patients not giving consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Improvement in PaO2/FiO2 <br/ ><br>2. Improvement in PaO2 <br/ ><br>3.Improvement in Respiratory rate <br/ ><br>4. Improvement in SpO2Timepoint: 1. Improvement in PaO2/FiO2 after 72 hours of HFNC/ NIV <br/ ><br>2. Improvement in PaO2 after 72 hours of HFNC / NIV <br/ ><br>3.Improvement in Respiratory rate after 72 hours of HFNC / NIV <br/ ><br>4. Improvement in SpO2
Secondary Outcome Measures
NameTimeMethod
To study efficacy of NIV and HFNC in patients with moderate to severe pneumonia. <br/ ><br>2. To study compliance of NIV and HFNC in patients.Timepoint: From application till 72 hours.
© Copyright 2025. All Rights Reserved by MedPath